GPUS Sets $750M Floor for Michigan Campus Sale; Operational Milestones Still Critical

What happened

Hyperscale Data announced management has set a $750 million minimum valuation for its Michigan AI data center campus, with management believing the value could reach or exceed $1.25 billion. This press release appears aimed at signaling a possible strategic sale, but it comes from management rather than an independent appraisal, and the figures dwarf the company's current market capitalization of roughly $81 million. The announcement arrives just one week before the company's contractual deadline to have Phase 1 (10MW) ready for service under its existing AI colocation agreement, a make-or-break milestone for the investment thesis. Meanwhile, the company continues to face significant dilution risk, having already sold 137.6 million shares under its ATM and carrying a $100–$120 million retrofit funding gap. As a result, while the news may create speculative interest, it does not solve the fundamental execution and financing challenges that currently keep the stock rated WAIT.

Implication

The management-set $750 million floor is a self-serving assertion without independent validation, and management has a history of promotional disclosures. Even if the campus has strategic value, realizing that value requires either a credible third-party offer or substantial operational progress that has not yet been demonstrated. The September 21 Phase 1 readiness deadline is only days away, and any slippage would further undermine confidence in the company's ability to execute. Additionally, the company's capital structure remains stretched, with heavy ATM usage and near-term debt maturities that force dilution into any rally. Therefore, until there is concrete evidence of a binding sale or on-time delivery, investors should remain on the sidelines and monitor upcoming disclosures.

Thesis delta

The new announcement adds a potential strategic alternative (sale of the Michigan campus) but does not change the core investment case, which hinges on operational delivery and funding. The valuation claim is management's own, lacks third-party support, and appears timed to influence sentiment ahead of the critical Phase 1 deadline. As such, the thesis remains WAIT with no upgrade triggered; we continue to watch for the September 21 readiness confirmation and any signs of reduced dilution.